Published in N Engl J Med on October 10, 1991
Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol (2009) 1.28
Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes. J Mol Diagn (2000) 1.01
TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Am J Pathol (1997) 0.99
Primary cutaneous lymphomas: diagnosis and treatment. Postepy Dermatol Alergol (2015) 0.84
Treatment relapsed subcutaneous panniculitis-like T-cell lymphoma together HPS by Cyclosporin A. Hematol Rep (2010) 0.84
Delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med (1992) 0.75
CD3+, CD56+, CD4-, CD8-, CD20-, CD30- Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report. Indian J Dermatol (2017) 0.75
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med (1998) 7.48
Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med (1999) 6.04
The leader peptide of yeast gene CPA1 is essential for the translational repression of its expression. Cell (1987) 4.91
Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood (2000) 3.60
Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med (1999) 3.37
Rituximab therapy of patients with B-cell chronic lymphocytic leukemia. Blood (2001) 2.50
Four years of experience with silver-copper ionization for control of legionella in a german university hospital hot water plumbing system. Clin Infect Dis (1999) 2.24
Anatomical variations of the median nerve in the carpal tunnel. J Hand Surg Am (1977) 2.07
Gamma/delta T-cell stimulation by pamidronate. N Engl J Med (1999) 2.04
Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J Clin Invest (1996) 2.00
Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood (2001) 1.74
Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol (1991) 1.68
HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol (1986) 1.63
The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res (1997) 1.59
Nucleotide sequence of the Bacillus subtilis xylose isomerase gene: extensive homology between the Bacillus and Escherichia coli enzyme. Nucleic Acids Res (1985) 1.57
Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer (1997) 1.50
[Post-traumatic carpal collapse. Follow-up and therapeutic concept]. Unfallchirurg (2000) 1.48
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. J Clin Oncol (1998) 1.46
Clinical-scale single-step CD4(+) and CD8(+) cell depletion for donor innate lymphocyte infusion (DILI). Bone Marrow Transplant (2007) 1.46
Basal cell carcinomas in a tertiary referral centre: a systematic analysis. Br J Dermatol (2014) 1.46
A segment of mRNA encoding the leader peptide of the CPA1 gene confers repression by arginine on a heterologous yeast gene transcript. Mol Cell Biol (1994) 1.43
PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res (2001) 1.42
Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) treatment. Blood (2001) 1.41
In melanoma, beta-catenin is a suppressor of invasion. Oncogene (2011) 1.40
[Listing in the journal citation reports and impact factor--a milestone for the journal]. Handchir Mikrochir Plast Chir (2006) 1.39
Comment on "Intra-abdominal hypertension and abdominal compartment syndrome after endovascular repair of ruptured abdominal aortic aneurysm". Eur J Vasc Endovasc Surg (2011) 1.38
Increased metal allergy in patients with failed metal-on-metal hip arthroplasty and peri-implant T-lymphocytic inflammation. Allergy (2009) 1.37
The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther (1998) 1.36
Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol (2001) 1.35
Mast cells migrate from blood to brain. J Neurosci (2000) 1.34
Thymic lymphomas in interleukin 9 transgenic mice. Oncogene (1994) 1.33
Selective cloning of Bacillus subtilis xylose isomerase and xylulokinase in Escherichia coli genes by IS5-mediated expression. EMBO J (1984) 1.32
Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood (1997) 1.27
Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc Natl Acad Sci U S A (2001) 1.24
German health-related environmental monitoring: assessing time trends of the general population's exposure to heavy metals. Int J Hyg Environ Health (2013) 1.23
What is CD4+CD56+ malignancy and how should it be treated? Bone Marrow Transplant (2003) 1.22
Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Clin Oncol (1997) 1.20
Chromosomal rearrangements affecting biofilm production and antibiotic resistance in a Staphylococcus epidermidis strain causing shunt-associated ventriculitis. Int J Med Microbiol (2000) 1.19
Comparison of free-living amoebae in hot water systems of hospitals with isolates from moist sanitary areas by identifying genera and determining temperature tolerance. Appl Environ Microbiol (1998) 1.18
Patterns of polarity in the Escherichia coli car AB gene cluster. J Bacteriol (1980) 1.17
Biomarkers in melanoma. Ann Oncol (2009) 1.17
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma. Ann Oncol (2010) 1.17
Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders. J Clin Invest (1986) 1.17
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Ann Oncol (2011) 1.16
Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride. J Hosp Infect (2003) 1.16
The effects of economic conditions and access to reproductive health services on state abortion rates and birthrates. Fam Plann Perspect (1997) 1.15
Mercury concentrations in urine, scalp hair, and saliva in children from Germany. J Expo Anal Environ Epidemiol (2002) 1.14
Human immunodeficiency virus infection in microglia: correlation between cells infected in the brain and cells cultured from infectious brain tissue. Ann Neurol (1992) 1.14
Phylogeny and dating of some pathogenic keratinophilic fungi using small subunit ribosomal RNA. J Med Vet Mycol (1996) 1.14
Nucleotide sequence of yeast gene CP A1 encoding the small subunit of arginine-pathway carbamoyl-phosphate synthetase. Homology of the deduced amino acid sequence to other glutamine amidotransferases. Eur J Biochem (1985) 1.12
Human wig-1, a p53 target gene that encodes a growth inhibitory zinc finger protein. Oncogene (2001) 1.12
Promoter mapping and selection of operator mutants by using insertion of bacteriophage Mu in the argECBH divergent operon of Escherichia coli K-12. J Bacteriol (1982) 1.11
Trisomy 3 is not a common feature in malignant lymphomas of mucosa-associated lymphoid tissue type. Am J Pathol (1998) 1.11
HMG-D is an architecture-specific protein that preferentially binds to DNA containing the dinucleotide TG. EMBO J (1995) 1.10
Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood (1995) 1.10
Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol (1996) 1.09
Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature. Br J Dermatol (2003) 1.09
Peripheral T/NK-cell lymphoma: a report of the IXth Workshop of the European Association for Haematopathology. Histopathology (2001) 1.08
Small molecules and targeted therapies in distant metastatic disease. Ann Oncol (2009) 1.08
[Ischemic muscle necroses]. Hefte Unfallheilkd (1979) 1.08
Menthol suppresses nicotinic acetylcholine receptor functioning in sensory neurons via allosteric modulation. Chem Senses (2012) 1.08
Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood (1998) 1.07
A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol (2008) 1.06
The optimal use of bexarotene in cutaneous T-cell lymphoma. Br J Dermatol (2007) 1.06
Rumination syndrome: an emerging case scenario. South Med J (2008) 1.04
Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas. Genes Chromosomes Cancer (1998) 1.04
A nonameric core sequence is required upstream of the LYS genes of Saccharomyces cerevisiae for Lys14p-mediated activation and apparent repression by lysine. Mol Microbiol (1998) 1.04
Interactions between Ty1 retrotransposon RNA and the T and D regions of the tRNA(iMet) primer are required for initiation of reverse transcription in vivo. Mol Cell Biol (1998) 1.03
Use of gene cloning to determine polarity of an operon: genes carAB of Escherichia coli. J Bacteriol (1980) 1.03
Qualitative and (semi)quantitative characterization of nasal and skin methicillin-resistant Staphylococcus aureus carriage of hospitalized patients. Int J Hyg Environ Health (2004) 1.03
[The "open-palm" technic in the treatment of Dupuytren's contracture]. Handchirurgie (1977) 1.02
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). Br J Cancer (2001) 1.02
Subcutaneous panniculitis-like T-cell lymphoma during pregnancy with successful autologous stem cell transplantation. Ann Hematol (2003) 1.01
Molecular differentiation of dermatophyte fungi. Mycoses (1999) 1.01
Noncardiac surgery in patients with left ventricular assist devices. Surgery (2001) 1.01
Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions. Circulation (1998) 1.01
Revision surgery after carpal tunnel release--analysis of the pathology in 200 cases during a 2 year period. J Hand Surg Br (2005) 1.00
Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J Invest Dermatol (2001) 1.00
Vgamma9/Vdelta2 T cell activation induced by bacterial low molecular mass compounds depends on the 1-deoxy-D-xylulose 5-phosphate pathway of isoprenoid biosynthesis. FEMS Immunol Med Microbiol (1999) 0.99
Patterns of subchondral bone mineralization in the wrist after midcarpal fusion. J Hand Surg Am (1999) 0.99
Correlation of Pneumocystis carinii PCR with clinical diagnosis in immunocompromised patients. Lancet (1996) 0.99
Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas. J Pathol (1996) 0.99
Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma. Arch Dermatol (2000) 0.99
Arthroscopic repair of subscapularis tear: Surgical technique and results. Orthop Traumatol Surg Res (2010) 0.98
MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution. Am J Pathol (1997) 0.98
Aluminum load in chronic intermittent plasma exchange. J Toxicol Clin Toxicol (1987) 0.98
[Abrasion injury: combined burn injury of the hand]. Handchir Mikrochir Plast Chir (1985) 0.97
Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coagul Fibrinolysis (1992) 0.96
Dual regulation of the synthesis of the arginine pathway carbamoylphosphate synthase of Saccharomyces cerevisiae by specific and general controls of amino acid biosynthesis. Mol Gen Genet (1979) 0.96
Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie (2004) 0.96
MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. Br J Cancer (2010) 0.96
Analysis of 8-oxo-7,8-dihydro-2'-deoxyguanosine and DNA strand breaks in white blood cells of occupationally exposed workers: comparison with ambient monitoring, urinary metabolites and enzyme polymorphisms. Carcinogenesis (2002) 0.95
Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses. J Mol Med (Berl) (2001) 0.95